aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Reify Health, founded with the mission to accelerate the development of life-saving therapies, offers cloud-based software solutions aimed at enhancing the efficiency and productivity of clinical trials. Their flagship product, StudyTeam™, is designed to help clinical trial teams achieve faster and more predictable patient enrollment while reducing administrative burdens. Reify Health focuses on the healthcare and pharmaceutical markets, providing tools that streamline the clinical trial process and improve outcomes for patients and researchers alike.
Notable figures associated with Reify Health include its founders and key investors from prominent venture capital firms. The company has achieved significant milestones, including widespread adoption of StudyTeam™ by leading pharmaceutical companies and clinical research organizations. Reify Health's impact is evident in its contribution to accelerating clinical trials, ultimately bringing new therapies to market more quickly and improving patient care globally.
Operating Status
Active
Ownership Type(s)
Venture Capital, Private Equity
Main Product(s)
Clinical Trial Software
Technology
Cloud
Tags
Healthtech, SaaS
Model Types
Platform, Software
Revenue Type(s)
Recurring
Customer Type(s)
Enterprise
Geographic Exposure
Global
When was Reify Health founded?
Reify Health was founded in 2012.
Where is Reify Health’s headquarters located?
Reify Health’s headquarters is located in Boston, MA, US.
When was Reify Health’s last funding round?
Reify Health’s most recent funding round was for $220M (USD) in April 2022.
How many employees does Reify Health have?
Reify Health has 1000 employees as of Feb 5, 2024.
How much has Reify Health raised to-date?
As of July 05, 2023, Reify Health has raised a total of $479.6M (USD) since Apr 21, 2022.
Add Comparison
Total Raised to Date
$479.6M
USD
Last Update Apr 21, 2022
Last Deal Details
$220M
USD
Apr 21, 2022
Series D
Total Employees Over Time
1000
As of Feb 2024
Reify Health Address
33 Arch Street
17th Floor
Boston,
Massachusetts
02110
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts